<DOC>
	<DOCNO>NCT00589979</DOCNO>
	<brief_summary>Patients knee pain due Osteoarthritis ( OA ) experience sub-optimal pain relief current analgesic regimen participate pilot clinical trial evaluate effectiveness tolerability Lidoderm Patch compare placebo treat knee pain OA .</brief_summary>
	<brief_title>Efficacy Safety Lidoderm Patch Applied Patients With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Key Inclusion criterion : Male female patient ≥37 year moderatetosevere OA relate pain one knee Body mass index ( BMI ) ≤40 kg/m2 Symptomatic OA index knee diagnose functional capacity II III accord ACR criterion classification Note : Patients symptomatic contralateral knee OA persistent pain ≤2 cm 010 cm PINRS ≥2 month allow participate . Unchanged dose analgesic medication OA least 4 week prior screen duration study Able willing complete paper ediary assessment require protocol Key Exclusion criterion : Pain joint index joint could interfere patient 's assessment pain index joint Compromised integrity intact , superficial skin layer A grade 1 4 Kellgren Lawrence score radiographic examination Recent injury either knee cause pain interference daily activity ( eg . walking ) Recent surgery/procedure either knee causing pain could interfere study assessment pain , function , QoL Known hypersensitivity allergy lidocaine , local anesthetic amide type , component product</criteria>
	<gender>All</gender>
	<minimum_age>37 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>Lidoderm</keyword>
	<keyword>Lidocaine</keyword>
	<keyword>Topical patch</keyword>
	<keyword>Adjunct therapy</keyword>
</DOC>